TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer-Reference-Cited by-同舟云学术

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Published:2016-08-08 Issue:37 Volume:7 Page:59441-59457
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tarpgaard Line S.¹,Ørum-Madsen Maj Sofie²,Christensen Ib J.³,Nordgaard Cathrine²,Noer Julie²,Guren Tormod K.⁴,Glimelius Bengt⁵,Sorbye Halfdan⁶⁷,Ikdahl Tone⁸,Kure Elin H.⁹,Tveit Kjell M.⁸,Nielsen Hans J.¹⁰,Pfeiffer Per¹,Brünner Nils²,Moreira José M. A.²

Affiliation:

1. Department of Oncology, Odense University Hospital, Odense, Denmark and University of Southern Denmark, Odense, Denmark

2. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

3. The Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark and Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark

4. Department of Oncology and K. G. Jebsen Centre for Colorectal Cancer Research, Oslo University Hospital Oslo, Norway

5. Departments of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala and Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

6. Department of Oncology, Haukeland University Hospital, Bergen, Norway

7. Department of Clinical Science, University of Bergen, Bergen, Norway

8. Department of Oncology, Oslo University Hospital, Oslo, Norway

9. Department of Genetics, Oslo University Hospital, Oslo, Norway

10. Department of Surgical Gastroenterology, Copenhagen University Hospital, Hvidovre, Denmark

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoids as regulators of TIMPs expression in cancer: Consequences, opportunities, and challenges;Life Sciences;2022-11

2. Cancer cell‑induced tissue inhibitor of metalloproteinase‑1 secretion by cancer‑associated fibroblasts promotes cancer cell migration;Oncology Reports;2022-04-27

3. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis;BMC Cancer;2020-07-15

4. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta‑analysis of multi‑platform datasets;Oncology Letters;2019-11-04

5. Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer;Molecular Oncology;2019-10-24